BRPI0703127A2 - composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia - Google Patents

composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia

Info

Publication number
BRPI0703127A2
BRPI0703127A2 BRPI0703127-0A BRPI0703127A BRPI0703127A2 BR PI0703127 A2 BRPI0703127 A2 BR PI0703127A2 BR PI0703127 A BRPI0703127 A BR PI0703127A BR PI0703127 A2 BRPI0703127 A2 BR PI0703127A2
Authority
BR
Brazil
Prior art keywords
spp
bacteria
acute
treatment
caused
Prior art date
Application number
BRPI0703127-0A
Other languages
English (en)
Inventor
Jardel Massari
Dolivar Coraucci Neto
Original Assignee
Ouro Fino Participacoes E Empreendimentos Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ouro Fino Participacoes E Empreendimentos Sa filed Critical Ouro Fino Participacoes E Empreendimentos Sa
Priority to BRPI0703127-0A priority Critical patent/BRPI0703127A2/pt
Priority to US12/671,750 priority patent/US20110275602A1/en
Priority to PCT/BR2008/000248 priority patent/WO2009023943A1/en
Priority to BRPI0806095-9A priority patent/BRPI0806095A2/pt
Publication of BRPI0703127A2 publication Critical patent/BRPI0703127A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSIçãO PARA O TRATAMENTO DE OTITES AGUDAS OU CRÈNICAS CAUSADAS POR FUNGOS E/OU BACTéRIAS EM ANIMAIS DE COMPANHIA. A presente invenção refere-se a uma nova associação composta por um antibiótico da classe das quinolonas, denominado Ciprofloxacina; um antifúngico azólico - Cetoconazol; um antiinflamatório corticóide - Fluocinolona e um anestésico local da classe das aminas - Lidocaína, destinada para o tratamento das otites agudas ou crónicas em animais de companhia, particularmente cães e gatos, causadas por bactérias: Staphylococcus intermedius, Staphylococcus aureus, Staphylococcus spp, Streptococcus spp, Streptococcus pyo genes, Proteus mirabilis, Proteus vulgaris, Proteus spp, Pseudomonas aeruginosa, Escherichia coli, Corynebacterium spp e demais bactérias. Fungos. Mailassezia pachydermatis (Pityrosporum canis), Epidermophyton floccosum, Microsporum canis, Trichophyton rubrum, Trichophyton mentagrophytes, Candida spp entre outros.
BRPI0703127-0A 2007-08-22 2007-08-22 composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia BRPI0703127A2 (pt)

Priority Applications (4)

Application Number Priority Date Filing Date Title
BRPI0703127-0A BRPI0703127A2 (pt) 2007-08-22 2007-08-22 composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia
US12/671,750 US20110275602A1 (en) 2007-08-22 2008-08-18 Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals
PCT/BR2008/000248 WO2009023943A1 (en) 2007-08-22 2008-08-18 Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals
BRPI0806095-9A BRPI0806095A2 (pt) 2007-08-22 2008-08-18 associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0703127-0A BRPI0703127A2 (pt) 2007-08-22 2007-08-22 composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia

Publications (1)

Publication Number Publication Date
BRPI0703127A2 true BRPI0703127A2 (pt) 2009-04-14

Family

ID=40377770

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0703127-0A BRPI0703127A2 (pt) 2007-08-22 2007-08-22 composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia
BRPI0806095-9A BRPI0806095A2 (pt) 2007-08-22 2008-08-18 associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0806095-9A BRPI0806095A2 (pt) 2007-08-22 2008-08-18 associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia

Country Status (3)

Country Link
US (1) US20110275602A1 (pt)
BR (2) BRPI0703127A2 (pt)
WO (1) WO2009023943A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011076721A1 (en) 2009-12-22 2011-06-30 Deutsches Krebsforschungszentrum Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases
EP2654637A1 (en) 2010-12-23 2013-10-30 Boehringer Ingelheim Vetmedica GmbH Kit-in-parts for cleaning and treating ears of companion animals
WO2016157929A1 (ja) * 2015-03-31 2016-10-06 国立研究開発法人産業技術総合研究所 インターフェロンαの経口投与による慢性難治性外耳炎治療効果

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050043251A1 (en) * 2003-08-20 2005-02-24 Fairfield Clinical Trials, Llc Method of treatment of otitis externa
US20070054844A1 (en) * 2003-08-20 2007-03-08 Fairfield Clinical Trials, Llc Method for treating otitis externa
WO2005055921A2 (en) * 2003-12-12 2005-06-23 Eran Eilat Compositions for treatment of ear disorders and methods of use thereof
CN101039668A (zh) * 2004-08-13 2007-09-19 先灵-普劳有限公司 包含抗菌素、三唑和皮质类固醇的药物制剂

Also Published As

Publication number Publication date
WO2009023943A1 (en) 2009-02-26
BRPI0806095A2 (pt) 2009-11-17
WO2009023943A8 (en) 2009-10-15
US20110275602A1 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
Cazoto et al. Antibacterial activity of violacein against Staphylococcus aureus isolated from bovine mastitis
Eames et al. Microbiological analysis of epidermal growth factor receptor inhibitor therapy‐associated paronychia
BR112016006589A2 (pt) composição, e composição de vacina
BRPI0703127A2 (pt) composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia
WO2020061375A8 (en) Antibacterial compounds
PH12021551143A1 (en) Novel imidazole derivative
May et al. Antibacterial effect of N‐acetylcysteine on common canine otitis externa isolates
BR112022009880A2 (pt) Composição de extratos naturais com atividade antibacteriana ou bacteriostática também para bactérias gram-negativas
BRPI0700969A (pt) composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia
NZ713357A (en) Antimicrobial compounds and methods of making and using the same
TW201129364A (en) Eye drop for treating eye infection disease containing levofloxacin or its salt or solvate thereof
Aonofriesei Effect of methylpyrazoles and coumarin association on the growth of Gram-negative bacteria
Al-Salahi et al. Antibacterial activity of newly synthesized 5-hydrazono-triazoloquinazolines
Detusheva et al. Susceptibility of Nosocomial K. pneumoniae, P. aeruginosa, A. baumannii, and P. mirabilis Strains to a Chlorhexidine-Based Antiseptic Preparation
Anitha et al. Efficacy of antibacterial activity of garlic cloves from Tamil Nadu and Jowai region.
MAMTA Identification of Bovine Mastitis Associated Pathogens by Conventional and Mass Spectrometry Methods
RU2020123463A (ru) Вакцина для профилактики мастита у крупного рогатого скота
DURÁN CHÁVEZ et al. Bacterial Resistance and Sensitivity in Urine Cultures in a Women Population in Ecuador
Cengiz et al. Assessment of synergistic interactions of danofloxacin and orbifloxacin against quinolone-resistant Escherichia coli isolated from animals by the checkerboard and time-kill methods
Pestova et al. MICROBIAL ASSOCIATIONS IN PATIENTS WITH CHRONIC RHINOSINUSITIS
BR112023017203A2 (pt) Derivado de ácido bórico que age como inibidor de beta-lactamase
Bajon et al. Antibacterial activity of Sandoricum koetjape (Santol) leaf ethanolic extract against Staphylococcus aureus and Escherichia coli
Lindgren et al. Eradication of MRSA throat carriage-a randomized trial comparing topical treatment with rifampicin-based systemic therapy
Mahmood et al. The effect of germinated wheat extractions Triticum aestivum on some pathogenic bacterial species isolated from burns infections
MD4600B1 (ro) Compus hidrazonic al acidului 4-formil-3-hidroxi-2-naftoic care manifestă activitate antimicrobiană

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B11K Dismissal acc. art. 17, par 2 of ipl - pending earlier application (priority claim) definitively shelved

Free format text: PRIORIDADE INTERNA DO PEDIDO PI 0806095-9.

B03G Publication of an application: publication cancelled [chapter 3.7 patent gazette]

Free format text: REFERENTE A RPI 1997 DE 14/04/2009.

B03F Publication of an application: publication of application definitely dismissed [chapter 3.6 patent gazette]